Sanofi-Aventis (SNY) is reportedly preparing for a major acquisition in the U.S. that could be...

|About: Sanofi (SNY)|By:, SA News Editor

Sanofi-Aventis (SNY) is reportedly preparing for a major acquisition in the U.S. that could be worth $20B or more, as it tries to replace revenue from drugs facing competition from generics. The process is still in "very early" stages and the acquisition target couldn't be identified.